journal article·2017-08Open access

Opinion on the recent development of injectable biomaterials for treating myocardial infarction

Wei Wang, Shuang Liang, WenGuang Liu

Abstract

Science China Technological Sciences -
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: expertdata · Quality: needs review · Source record ↗
Source flags: short_text

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Cardiac Fibrosis and Remodeling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (10)

Show source-provided references
1. Benjamin E J, Blaha M J, Chiuve S E, et al. Heart disease and stroke statistics—2017 update: A report from the american heart association. Circulation, 2017, 135: e146–e60310.1161/CIR.0000000000000485 ↗
2. Zhu Y, Matsumura Y, Wagner W R. Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences. Biomaterials, 2017, 129: 37–5310.1016/j.biomaterials.2017.02.032 ↗
3. Wang R M, Christman K L. Decellularized myocardial matrix hydrogels: In basic research and preclinical studies. Adv Drug Deliv Rev, 2016, 96: 77–8210.1016/j.addr.2015.06.002 ↗
4. Stoppel W L, Kaplan D L, Black Iii L D. Electrical and mechanical stimulation of cardiac cells and tissue constructs. Adv Drug Deliv Rev, 2016, 96: 135–15510.1016/j.addr.2015.07.009 ↗
5. Sepantafar M, Maheronnaghsh R, Mohammadi H, et al. Stem cells and injectable hydrogels: Synergistic therapeutics in myocardial repair. Biotech Adv, 2016, 34: 362–37910.1016/j.biotechadv.2016.03.003 ↗
6. Bao R, Tan B, Liang S, et al. A p-p conjugation-containing soft and conductive injectable polymer hydrogel highly efficiently rebuilds cardiac function after myocardial infarction. Biomaterials, 2017, 122: 63–7110.1016/j.biomaterials.2017.01.012 ↗
7. Hnatiuk A P, Ong S G, Olea F D, et al. Allogeneic mesenchymal stromal cells overexpressing mutant human hypoxia-inducible factor 1-a (HIF1-a) in an ovine model of acute myocardial infarction. J Am Heart Assoc, 2016, 5: e00371410.1161/JAHA.116.003714 ↗
8. Luo L, Tang J, Nishi K, et al. Fabrication of synthetic mesenchymal stem cells for the treatment of acute myocardial infarction in micenovelty and significance. Circ Res, 2017, 120: 1768–177510.1161/CIRCRESAHA.116.310374 ↗
9. Nguyen M M, Gianneschi N C, Christman K L. Developing injectable nanomaterials to repair the heart. Curr Opin Biotech, 2015, 34: 225–23110.1016/j.copbio.2015.03.016 ↗
10. Nguyen M M, Carlini A S, Chien M P, et al. Enzyme-responsive nanoparticles for targeted accumulation and prolonged retention in heart tissue after myocardial infarction. Adv Mater, 2015, 27: 5547–555210.1002/adma.201502003 ↗